American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws—2022 update

SL Ruggiero, TB Dodson, T Aghaloo… - Journal of oral and …, 2022 - Elsevier
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of
the jaws (MRONJ)–formerly referred to as bisphosphonate-related osteonecrosis of the jaws …

[PDF][PDF] Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation

AM Boyce, MT Collins - Endocrine reviews, 2020 - academic.oup.com
Abstract Fibrous dysplasia/McCune-Albright syndrome (FD/MAS) is a rare disorder of
striking complexity. It arises from somatic, gain-of-function mutations in GNAS, leading to …

Safety and efficacy of denosumab for fibrous dysplasia of bone

LF de Castro, Z Michel, K Pan, J Taylor… - … England Journal of …, 2023 - Mass Medical Soc
Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

[HTML][HTML] Fibrous dysplasia/mccune-albright syndrome

V Szymczuk, P Florenzano, LF de Castro… - GeneReviews® …, 2024 - ncbi.nlm.nih.gov
Fibrous dysplasia/McCune-Albright syndrome (FD/MAS), the result of an early embryonic
postzygotic somatic activating pathogenic variant in GNAS (encoding the cAMP pathway …

The clinical spectrum of McCune-Albright syndrome and its management

T Spencer, KS Pan, MT Collins… - Hormone research in …, 2020 - karger.com
McCune-Albright syndrome (MAS) is a rare, mosaic disorder presenting along a broad
clinical spectrum. Disease arises from somatic-activating GNAS mutations, leading to …

Fibrous dysplasia of bone and McCune–Albright syndrome: a bench to bedside review

I Hartley, M Zhadina, MT Collins, AM Boyce - Calcified tissue international, 2019 - Springer
Fibrous dysplasia is an uncommon mosaic disorder in which bone is replaced by structurally
unsound fibro-osseous tissue. It is caused by the sporadic post-zygotic activating mutations …

A rare skeletal disorder, fibrous dysplasia: a review of its pathogenesis and therapeutic prospects

HY Kim, JH Shim, CY Heo - International Journal of Molecular Sciences, 2023 - mdpi.com
Fibrous dysplasia (FD) is a rare, non-hereditary skeletal disorder characterized by its chronic
course of non-neoplastic fibrous tissue buildup in place of healthy bone. A myriad of factors …

[HTML][HTML] COVID-19 pandemic and osteoporosis in elderly patients

J Tang - Aging and disease, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), which is caused by an infection of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly becoming a worldwide …

Denosumab in patients with fibrous dysplasia previously treated with bisphosphonates

BCJ Majoor, SE Papapoulos… - The Journal of …, 2019 - academic.oup.com
Abstract Context Fibrous dysplasia/McCune-Albright syndrome (FD/MAS) is a rare bone
disorder commonly treated with bisphosphonates, but clinical and biochemical responses …

The roles of RANK/RANKL/OPG in cardiac, skeletal, and smooth muscles in health and disease

L Marcadet, Z Bouredji, A Argaw… - Frontiers in Cell and …, 2022 - frontiersin.org
Although their physiology and functions are very different, bones, skeletal and smooth
muscles, as well as the heart have the same embryonic origin. Skeletal muscles and bones …